Suppr超能文献

微小RNA-377通过靶向细胞周期蛋白依赖性激酶6抑制人骨肉瘤MG-63细胞的增殖。

microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6.

作者信息

Wang Liang, Shao Jianli, Zhang Xia, Xu Meng, Zhao Jianfu

机构信息

Department of Oncology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, People's Republic of China,

出版信息

Tumour Biol. 2015 May;36(5):3911-7. doi: 10.1007/s13277-014-3034-2. Epub 2015 Jan 11.

Abstract

MicroRNAs (miRNAs) are essential to the progression of osteosarcoma. Previous research using osteosarcoma samples confirmed that miR-377 expression is less than that observed in normal human osteoblast expression. These data suggest a role for miR-377 in osteosarcoma that warrants investigation. To address this concept, we measured miR-377 expression in two cell models, and we also observed that miR-377 was less expressed in osteosarcoma MG-63 cells compared to the hFOB1.19 human fetal osteoblastic cell line. Moreover, miR-377 overexpression reduced cell proliferation and suppressed invasion of MG-63 cells but had no effect on MG-63 cell apoptosis. Because cyclin-dependent kinase 6 (CDK6) may be a potential target of miR-377 in osteosarcoma cells, we overexpressed CDK6 and observed that overexpression attenuated tumor suppressive effects of miR-377 on cell proliferation. Our data suggest that miR-377 can suppress proliferation in MG-63 cells in part by targeting CDK6.

摘要

微小RNA(miRNA)对骨肉瘤的进展至关重要。先前使用骨肉瘤样本的研究证实,miR-377的表达低于在正常人成骨细胞中的表达。这些数据表明miR-377在骨肉瘤中发挥作用,值得进一步研究。为了验证这一观点,我们在两种细胞模型中检测了miR-377的表达,并且我们还观察到与hFOB1.19人胎儿成骨细胞系相比,miR-377在骨肉瘤MG-63细胞中的表达较低。此外,miR-377的过表达降低了细胞增殖并抑制了MG-63细胞的侵袭,但对MG-63细胞凋亡没有影响。由于细胞周期蛋白依赖性激酶6(CDK6)可能是骨肉瘤细胞中miR-377的潜在靶点,我们过表达了CDK6,并观察到过表达减弱了miR-377对细胞增殖的肿瘤抑制作用。我们的数据表明,miR-377可以部分通过靶向CDK6来抑制MG-63细胞的增殖。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验